Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives $22.30 Average Price Target from Analysts

Posted by Stanley Muller on May 28th, 2026

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are currently covering the firm, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $22.30.

SBRA has been the topic of a number of research analyst reports. Scotiabank boosted their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “sector perform” rating in a research note on Thursday, May 21st. Citizens Jmp upped their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a research report on Wednesday, February 18th. Truist Financial raised their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. UBS Group upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Finally, Weiss Ratings lowered Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Friday, May 1st.

Check Out Our Latest Research Report on SBRA

Hedge Funds Weigh In On Sabra Healthcare REIT

Institutional investors have recently made changes to their positions in the business. Cornerstone Wealth Management LLC increased its stake in Sabra Healthcare REIT by 256.6% in the third quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after acquiring an additional 28,625 shares during the period. AlphaQuest LLC lifted its holdings in shares of Sabra Healthcare REIT by 309.2% during the third quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock valued at $2,700,000 after acquiring an additional 109,444 shares during the period. Bank of Montreal Can lifted its holdings in shares of Sabra Healthcare REIT by 8.2% during the third quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock valued at $51,962,000 after acquiring an additional 211,686 shares during the period. Allianz Asset Management GmbH boosted its stake in shares of Sabra Healthcare REIT by 9.9% in the 3rd quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock valued at $16,832,000 after purchasing an additional 81,293 shares in the last quarter. Finally, Greenland Capital Management LP acquired a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at $4,194,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $20.45 on Friday. The firm has a fifty day simple moving average of $20.32 and a 200 day simple moving average of $19.69. Sabra Healthcare REIT has a twelve month low of $17.13 and a twelve month high of $21.28. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $5.16 billion, a PE ratio of 32.46, a P/E/G ratio of 1.56 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $221.75 million during the quarter, compared to analyst estimates of $209.20 million. During the same period in the previous year, the company posted $0.37 EPS. The firm’s revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts forecast that Sabra Healthcare REIT will post 1.5 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.